Kymera Therapeutics Inc. (KYMR)

33.26

-0.30 (-0.89%)

At close: Apr 25, 2025, 3:59 PM

33.79

1.61%

Pre-market: Apr 28, 2025, 06:57 AM EDT

Kymera Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Net Income	-223.86M	-146.96M	-154.81M	-100.22M	-45.59M	-41.25M	-21.47M
Depreciation & Amortization	7.37M	3.56M	2.98M	2.4M	1.76M	825K	205K
Stock-Based Compensation	55.01M	43.12M	35.48M	24.97M	5.19M	1.2M	648K
Other Working Capital	-38.66M	-7.73M	-37.88M	-71.26M	117.58M	55.78M	1.48M
Other Non-Cash Items	-9.06M	-5.23M	889K	5.83M	332K	443K	443K
Deferred Income Tax	n/a	n/a	n/a	n/a	1.57M	n/a	n/a
Change in Working Capital	-23.97M	2.68M	-37.62M	-61.92M	124.87M	56.69M	2.31M
Operating Cash Flow	-194.5M	-102.83M	-153.09M	-128.95M	88.13M	17.91M	-17.86M
Capital Expenditures	-12.84M	-34.48M	-2.84M	-1.6M	-9.1M	-532K	-1.36M
Cash Acquisitions	n/a	n/a	-20.52M	5.81M	413.49M	n/a	n/a
Purchase of Investments	-901.23M	-189.15M	-445.97M	-456.4M	-529.38M	-15.95M	n/a
Sales Maturities Of Investments	496M	363.52M	469.33M	358.17M	115.89M	n/a	n/a
Other Investing Acitivies	13.98M	n/a	20.52M	-5.81M	-413.49M	-15.95M	n/a
Investing Cash Flow	-404.08M	139.89M	20.52M	-99.83M	-422.59M	-16.49M	-1.36M
Debt Repayment	-1.58M	-76K	-1.13M	-849K	-554K	-371K	-295K
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	13.81M	4.27M	4.3M	8.02M	162K	74K	n/a
Financial Cash Flow	608.85M	4.19M	153M	250.28M	289.26M	34.91M	52.93M
Net Cash Flow	10.27M	41.25M	20.43M	21.5M	-45.2M	36.33M	33.71M
Free Cash Flow	-207.34M	-137.31M	-155.92M	-130.54M	79.03M	17.37M	-19.22M